Transpupillary thermotherapy for subfoveal neovascularization secondary to group 2A idiopathic juxtafoveolar telangiectasis.
作者信息
Shukla Dhananjay, Singh Jatinder, Kolluru Chandra Mohan, Kim Ramasamy, Namperumalsamy Perumalsamy
机构信息
Retina-Vitreous Service, Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, 1 Anna Nagar, Madurai 625-020, Tamil Nadu, India.
出版信息
Am J Ophthalmol. 2004 Jul;138(1):147-9. doi: 10.1016/j.ajo.2004.01.047.
PURPOSE
To evaluate the efficacy and safety of transpupillary thermotherapy (TTT) for subfoveal neovascularization (SRNVM) in patients with group 2A Idiopathic Juxtafoveolar Telangiectasis (IJFT).
DESIGN
Nonrandomized interventional case series.
METHODS
We performed TTT for subfoveal SRNVM in 14 eyes of 13 patients with group 2A IJFT, who were referred to our tertiary care center. We evaluated visual outcome and SRNVM closure rate in these patients.
RESULTS
After a mean follow-up period of 8.65 months, 92.3% of treated eyes had stabilization or improvement in visual acuity as well as regression of SRNVM by fluorescein angiography (FA). One SRNVM showed persistent leakage. One patient worsened by more than 2 Snellen lines; one required retreatment.
CONCLUSION
Transpupillary thermotherapy may be a safe and useful alternative treatment option for patients with group 2A IJFT with subfoveal SRNVM.
Zotero 插件